The point I am getting at: How will LLL be evaluated? Surely we...

The point I am getting at:
How will LLL be evaluated?
Surely we can't assume the value of LLL to be X verses an actual valuation, to which the in-specie shares are calculated.
The Company is trading at a market cap of $930M with combined assets of gold/lithium ~ how much is the gold valued at and how much is the Lithium valued at?

Do we go to the analyst's reports for calculations of the in-specie distribution?
Latest reports:
(1) Sprott (6/12) Total FFX Value (including Lithium) @ $A1,398 million ~ ascribed to Goulamina A$722million
https://firefinchltd.com/wp-content/uploads/SprottEquityResearchReportUpdatedGoulaminaDFS06Dec21.pdf
(2) Euroz / Hartley's (7/12) had an after tax valuation for FFX's 45% share of Goulamina @ A$725 million and a price target valuation of A$1.0b
https://firefinchltd.com/wp-content/uploads/EurozHartleysStrongGoulaminaEconomicsInUpdatedDFS07Dec21.pdf
(3) Canaccord (7/12) A valuation of $A873 million for Goulamina @45%
https://firefinchltd.com/wp-content/uploads/CanaccordGenuityGoulaminaUpdatedDFSRecapBiggerIsBetter07Dec21.pdf

If we use a rounded in between figure of $800 million, is the calculation for the in-specie then 800m/1,198 million? = .667 = for every 1,000 of FFX shares held you would receive 667 in-specie shares in LLL?

@Red Baron I personally hope you are correct that the in-specie comes before the entitlement offer, means it increase the amount of LLL pro rata shares I can subscribe to.......


cheers